Extensions

Based on a detailed analysis of the provided documentation for U.S. Patent 10,758,652, here are the findings regarding its term, continuation history, and related patent family.

Patent Term and Expiration

• Patent Term Adjustment (PTA): The patent has been granted a patent term adjustment. The standard 20-year term from its filing date of May 30, 2017, would end on May 30, 2037.
• Patent Term Extension (PTE): There is no indication of a Patent Term Extension (PTE) under 35 U.S.C. § 156, which is typically granted for delays in regulatory review by agencies like the FDA.
• Projected Expiration Date: The official adjusted expiration date for U.S. Patent 10,758,652, including all adjustments, is November 20, 2038. This is explicitly stated in the "Legal status" section of the patent's documentation (Source: https://patents.google.com/patent/[US10758652](/patent/US10758652)/en).

Continuation and Divisional Applications

The application that resulted in this patent, US15/608,183, is the parent for several subsequent applications. These are listed as "Related Child Applications" or are part of the broader patent family.

• Continuation-in-Part Application:

  • US15/793,339: Filed on October 25, 2017, which later issued as patent US10792416B2.

• Continuation Applications:

  • US16/866,078: Filed on May 4, 2020, which issued as patent US10980926B2.
  • US17/205,374: Filed on March 18, 2021, which issued as patent US12171916B2.
  • US17/943,410: Filed on September 13, 2022, which issued as patent US11738124B2.
  • US18/955,269: Filed on November 21, 2024, which is expected to issue as patent US12324873B2.
  • US19/202,281: Filed on May 8, 2025, which has been published as US20250269097A1.

• Divisional Applications: There are no applications explicitly identified as "divisional" in the provided documentation for this patent family.

Patent Family Members

U.S. Patent 10,758,652 is part of a large international patent family, indicating that the assignee, Haemonetics Corp., sought protection for this invention in numerous jurisdictions.

• U.S. Family Members (Issued Patents):

  • US10758652B2 (this patent)
  • US10792416B2
  • US10980926B2
  • US11738124B2
  • US12171916B2

• Foreign Family Members (Selected): The invention is also protected or pending in other countries, based on the priority filing.

  • Europe (EP): EP3634524B1, EP4600632A3
  • China (CN): CN110799223B, CN115300698A
  • Japan (JP): JP7257336B2, JP7565389B2
  • Australia (AU): AU2018275198C1, AU2023238237B2
  • Canada (CA): CA3064883A1
  • South Korea (KR): KR102585128B1, KR20230144112A
  • World Intellectual Property Organization (WO): WO2018222441A1